Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

NASA-Inspired 3D camera could spot cervical cancer early in poor regions

NCT ID NCT06810427

Diagnosis Sponsor: Carilion Clinic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new, low-cost handheld 3D camera called CervImage for spotting early signs of cervical cancer. Researchers want to see if the device takes clear, useful images and is easy for doctors to use. The study includes 18 women, some with known HPV or cervical changes and some healthy. It is an early design test, not a full check of whether the device improves diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
CervImage device
What this could lead to
If successful, this could lead to a simple, affordable tool for detecting early signs of cervical cancer in places where standard screening is hard to access.
What could go wrong
This is a very small, early-stage study with only 18 participants, focused on device design and image quality. It does not yet test whether the device actually improves diagnosis or health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

18 people

The number who actually took part.

Started

Jan 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 70 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient 21 to 70 years of age at screening * Patients with known HPV infection or cervical intraepithelial neoplasia (16 patients) * Healthy patients without history of HPV/CIN (2 patients) * Participants able to consent for themselves Exclusion Criteria: * Cognitive Impairment * Currently Pregnant * Incarcerated Individual * Any condition which in the clinical judgement of the PI makes the subject unsuitable or unsafe for study enrollment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical intraepithelial neoplasia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cervical intraepithelial neoplasia dysplasia of cervix

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical intraepithelial neoplasia

Contacts and locations

Locations

  • Carilion Clinic

    Roanoke, Virginia, 24013, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.